David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Healthcare | 13.44% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Financials | 7.19% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3076
CALL
GoDaddy
GDDY
$12.6B
| $376K | ﹤0.01% |
5,000
-2,900
| -37% | -$204K |
|
3077
PUT
NN Inc
NNBR
$292M
| $375K | ﹤0.01% |
50,000
-79,000
| -61% | -$701K |
|
|
RPAI
3078
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $374K | ﹤0.01% |
30,697
-30,041
| -49% | -$366K |
|
3079
Lumen
LUMN
$6.08B
| $373K | ﹤0.01% |
31,088
-126,660
| -80% | -$1.76M |
|
|
BKCC
3080
DELISTED
BlackRock Capital Investment Corporation
BKCC
| $373K | ﹤0.01% |
62,144
+21,454
| +53% | +$131K |
|
|
TTM
3081
DELISTED
Tata Motors Limited
TTM
| $373K | ﹤0.01% |
29,725
-24,500
| -45% | -$306K |
|
3082
American Airlines Group
AAL
$9.23B
| $371K | ﹤0.01% |
11,672
-923,075
| -99% | -$31M |
|
3083
PUT
Principal Financial Group
PFG
$23.9B
| $371K | ﹤0.01% |
7,400
| – | – |
|
|
HNGR
3084
DELISTED
Hanger Inc.
HNGR
| $370K | ﹤0.01% |
+19,439
| New | +$385K |
|
3085
PUT
Group 1 Automotive
GPI
$3.16B
| $369K | ﹤0.01% |
5,700
| – | – |
|
3086
KALA BIO
KALA
$15.9M
| $369K | ﹤0.01% |
18
-25
| -58% | -$444K |
|
3087
PUT
Deckers Outdoor
DECK
$12.1B
| $367K | ﹤0.01% |
15,000
-16,800
| -53% | -$382K |
|
3088
NETGEAR
NTGR
$581M
| $367K | ﹤0.01% |
11,068
-2,491
| -18% | -$90.4K |
|
3089
PUT
Melco Resorts & Entertainment
MLCO
$2.08B
| $364K | ﹤0.01% |
16,100
| – | – |
|
|
PRSU
3090
Pursuit Attractions and Hospitality Inc
PRSU
$1.33B
| $364K | ﹤0.01% |
6,475
-902
| -12% | -$48.8K |
|
3091
Papa John's
PZZA
$794M
| $363K | ﹤0.01% |
6,864
-10,154
| -60% | -$448K |
|
3092
Mettler-Toledo International
MTD
$28.1B
| $362K | ﹤0.01% |
500
+100
| +25% | +$65K |
|
3093
PUT
LGI Homes
LGIH
$1.37B
| $361K | ﹤0.01% |
6,000
-6,500
| -52% | -$376K |
|
3094
Larimar Therapeutics
LRMR
$432M
| $361K | ﹤0.01% |
10,984
-1,436
| -12% | -$73.6K |
|
3095
Madrigal Pharmaceuticals
MDGL
$11.8B
| $361K | ﹤0.01% |
+2,880
| New | +$358K |
|
3096
Banco de Chile
BCH
$21.5B
| $360K | ﹤0.01% |
12,228
-9,522
| -44% | -$293K |
|
3097
PUT
Duke Energy
DUK
$94.8B
| $360K | ﹤0.01% |
+4,000
| New | +$353K |
|
3098
CALL
Silgan Holdings
SLGN
$4.51B
| $359K | ﹤0.01% |
12,100
| – | – |
|
3099
Verisk Analytics
VRSK
$24.5B
| $359K | ﹤0.01% |
2,700
-100
| -4% | -$12.2K |
|
|
SBNY
3100
PUT
DELISTED
Signature Bank
SBNY
| $359K | ﹤0.01% |
2,800
-12,800
| -82% | -$1.63M |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.